BioCorRx (BICX) Receivables (2010 - 2026)
BioCorRx (BICX) posted Receivables of $452068.0 for Q1 2026, up 47.98% sequentially from $305485.0 in Q4 2025, and up 70.38% YoY from $265326.0 in Q1 2025.
BioCorRx (BICX) Receivables (2010 - 2026) Analysis & Trends
BioCorRx has reported Receivables for 17 years, with the latest figure at $452068.0 in Q1 2026.
- Quarterly Receivables rose 70.38% year-over-year to $452068.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $452068.0 (up 70.38% YoY) and the FY2025 annual result came in at $305485.0, up 504.48% from the prior year.
- Receivables improved to $452068.0 in Q1 2026 per BICX's latest filing, from $305485.0 in the prior quarter.
- Over five years, Receivables peaked at $1.5 million in Q3 2025 and troughed at $11893.0 in Q1 2022.
- A 5-year average of $235048.0 and a median of $109736.0 in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2024: Receivables soared 4446.13% in 2022, then sank 74.95% in 2024.
- Over 5 years, Receivables stood at $158030.0 in 2022, then plunged by 51.27% to $77006.0 in 2023, then jumped by 109.9% to $161638.0 in 2024, then soared by 88.99% to $305485.0 in 2025, then surged by 47.98% to $452068.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $452068.0, $305485.0, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 12.28 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 2.91 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 687.30 Mn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 3.03 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 676.80 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 2.80 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 723.91 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 188.63 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 299.82 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | 104,113.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104,113.00 |
| Mar 31, 2026 | 452,068.00 |
| Dec 31, 2025 | 305,485.00 |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 307,456.00 |
| Mar 31, 2025 | 265,326.00 |
| Dec 31, 2024 | 161,638.00 |
| Sep 30, 2024 | 314,170.00 |
| Jun 30, 2024 | 109,736.00 |
| Mar 31, 2024 | 21,042.00 |
| Dec 31, 2023 | 77,006.00 |
| Sep 30, 2023 | 17,206.00 |
| Jun 30, 2023 | 105,079.00 |
| Mar 31, 2023 | 83,994.00 |
| Dec 31, 2022 | 158,030.00 |
| Sep 30, 2022 | 68,192.00 |
| Jun 30, 2022 | 14,465.00 |
| Mar 31, 2022 | 11,893.00 |
| Dec 31, 2021 | 57,859.00 |
| Sep 30, 2021 | 1,500.00 |